145 related articles for article (PubMed ID: 8339273)
1. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
Brachman DG; Beckett M; Graves D; Haraf D; Vokes E; Weichselbaum RR
Cancer Res; 1993 Aug; 53(16):3667-9. PubMed ID: 8339273
[TBL] [Abstract][Full Text] [Related]
2. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
3. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the p53 gene in radiation-sensitive and -resistant human squamous carcinoma cells.
Jung M; Notario V; Dritschilo A
Cancer Res; 1992 Nov; 52(22):6390-3. PubMed ID: 1423286
[TBL] [Abstract][Full Text] [Related]
5. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
Gupta N; Vij R; Haas-Kogan DA; Israel MA; Deen DF; Morgan WF
Radiat Res; 1996 Mar; 145(3):289-98. PubMed ID: 8927696
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
8. The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival.
Pulkkinen JO; Servomaa K; Pekkola K; Kulmala J; Grenman R
Anticancer Res; 2000; 20(3A):1503-11. PubMed ID: 10928063
[TBL] [Abstract][Full Text] [Related]
9. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines.
O'Connor PM; Jackman J; Jondle D; Bhatia K; Magrath I; Kohn KW
Cancer Res; 1993 Oct; 53(20):4776-80. PubMed ID: 8402660
[TBL] [Abstract][Full Text] [Related]
10. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
11. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection.
Nagasawa H; Keng P; Maki C; Yu Y; Little JB
Cancer Res; 1998 May; 58(9):2036-41. PubMed ID: 9581850
[TBL] [Abstract][Full Text] [Related]
12. The bcl-2 gene status of human head and neck cancer cell lines.
Salo A; Servomaa K; Kiuru A; Pulkkinen J; Grénman R; Pekkola-Heino K; Rytömaa T
Acta Otolaryngol Suppl; 1997; 529():233-6. PubMed ID: 9288319
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
McIlwrath AJ; Vasey PA; Ross GM; Brown R
Cancer Res; 1994 Jul; 54(14):3718-22. PubMed ID: 8033090
[TBL] [Abstract][Full Text] [Related]
14. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair.
Kasten-Pisula U; Menegakis A; Brammer I; Borgmann K; Mansour WY; Degenhardt S; Krause M; Schreiber A; Dahm-Daphi J; Petersen C; Dikomey E; Baumann M
Radiother Oncol; 2009 Feb; 90(2):257-64. PubMed ID: 19038467
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
16. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
17. Correspondence Re: D. G. Brachman et al., Mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res., 53: 3667-3669, 1993.
Leith JT
Cancer Res; 1994 Sep; 54(18):5021. PubMed ID: 7980804
[No Abstract] [Full Text] [Related]
18. Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer.
Gallo O; Chiarelli I; Bianchi S; Calzolari A; Simonetti L; Porfirio B
Clin Cancer Res; 1996 Sep; 2(9):1577-82. PubMed ID: 9816336
[TBL] [Abstract][Full Text] [Related]
19. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.
Syljuåsen RG; Krolewski B; Little JB
Cancer Res; 1999 Mar; 59(5):1008-14. PubMed ID: 10070956
[TBL] [Abstract][Full Text] [Related]
20. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.
Slichenmyer WJ; Nelson WG; Slebos RJ; Kastan MB
Cancer Res; 1993 Sep; 53(18):4164-8. PubMed ID: 8364909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
